Freedom251 › AI Drug Discovery Software
Benevolent Platform
Facts from Benevolent Platform's own pages
- AI and data
- BenevolentAI describes its technology as using multimodal data to surface insights and accelerate biomedical discovery. · benevolent.com, 14 Nov 2026
- Audience
- BenevolentAI says its team supports scientists and executives using AI and machine learning in their work. · benevolent.com, 14 Nov 2026
- Collaborations
- The company names AstraZeneca and Merck among its pharmaceutical discovery collaboration partners. · benevolent.com, 14 Nov 2026
- Contact
- The company provides a press contact email address. · benevolent.com, 14 Nov 2026
- Drug discovery
- The company says it uses its platform, scientific expertise, and wet-lab facilities to accelerate novel drug discovery. · benevolent.com, 14 Nov 2026
- Focus
- In April 2024, BenevolentAI said it would focus on drug discovery collaborations and its proprietary pipeline. · benevolent.com, 14 Nov 2026
- Founded
- BenevolentAI's press kit lists 2013 as its founding year. · benevolent.com, 14 Nov 2026
- Headquarters
- The company describes itself as headquartered in London. · benevolent.com, 14 Nov 2026
- Knowledge Exploration Tools
- The company announced that work on its Knowledge Exploration Tools would cease after a market assessment. · benevolent.com, 14 Nov 2026
- Knowledge graph
- The company says its technology builds on investment in a knowledge graph and proprietary ontologies. · benevolent.com, 14 Nov 2026
- Platform development
- A 2024 company announcement stated that investment would continue in development of the BenevolentAI Platform. · benevolent.com, 14 Nov 2026
- Platform offering
- BenevolentAI describes its platform as integrating AI and science to uncover new biology, predict novel targets, and develop drugs for complex diseases. · benevolent.com, 14 Nov 2026
- Product availability
- The current homepage presents Qor as an always-on strategic function for biopharma decision makers and life science consultancies. · benevolent.com, 14 Nov 2026
Where Benevolent Platform stands on Freedom251
- AI Drug Discovery Software#10 of 33